Charles V. Baltic III is Director at MEI Pharma, Inc. (MEIP). They have made 11 open-market trades across 1 company since 2012, most recently 2023-02-28.
CIK 0001533340
10 open-market purchases totalling $204K since 2012, against 1 sale. Across 10 scored buys the stock is up 8.8% at ninety days, and 7.5 points ahead of the S&P over the same stretch.
10 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| MEIP | 105,750 | $325K |
Shares reported on the most recent Form 4, priced at the 2023-03-01 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 10% | 80% | 100% |
| Avg Move | -10.6% | +2.4% | +8.8% |
| Alpha | -5.9% | +1.7% | +7.5% |
| Scored | 10 | 10 | 10 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MEIP | BUY | 2023-02-28 | 2023-03-01 | $0.23 | $19K | +11.7% | -0.1% | +57.1% |
| MEIP | BUY | 2017-11-27 | 2017-11-29 | $2.25 | $25K | -3.6% | -5.4% | +1.4% |
| MEIP | SELL | 2017-11-27 | 2017-11-29 | $2.21 | $24K | -3.6% | -5.4% | +1.4% |
| MEIP | BUY | 2015-01-21 | 2015-01-23 | $3.81 | $19K | -14.3% | +3.7% | +3.7% |
| MEIP | BUY | 2014-12-31 | 2015-01-02 | $4.27 | $13K | -14.3% | +3.7% | +3.7% |
| MEIP | BUY | 2014-06-30 | 2014-07-02 | $6.56 | $13K | -14.3% | +3.7% | +3.7% |
| MEIP | BUY | 2013-08-16 | 2013-08-20 | $6.82 | $18K | -14.3% | +3.7% | +3.7% |
| MEIP | BUY | 2013-01-25 | 2013-01-29 | $6.04 | $62K | -14.3% | +3.7% | +3.7% |
| MEIP | BUY | 2013-01-24 | 2013-01-28 | $6.25 | $5K | -14.3% | +3.7% | +3.7% |
| MEIP | BUY | 2012-12-21 | 2012-12-26 | $7.18 | $25K | -14.3% | +3.7% | +3.7% |
| MEIP | BUY | 2012-07-05 | 2012-07-09 | $0.43 | $6K | -14.3% | +3.7% | +3.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.